RSV F Protein Compositions and Method for Making Same
GlaxoSmithKline Biologicals S.A.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 12/836,931, filed Jul 15, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,629,181 | RSV F Protein Compositions and Methods for Making Same In force · Medium confidence UsedRemaining | GlaxoSmithKline Biologicals S.A. | In force | Medium confidence | ||
| US 11,655,284 | RSV F Protein Compositions and Methods for Making Same In force · Low confidence | GlaxoSmithKline Biologicals S.A. | In force | Low confidence | ||
| US 11,820,812 | RSV F Protein Compositions and Methods for Making Same In force · High confidence | GlaxoSmithKline Biologicals S.A. | In force | High confidence | ||
| US 11,827,694 | RSV F Protein Compositions and Methods for Making Same In force · High confidence | GlaxoSmithKline Biologicals S.A. | In force | High confidence | ||
| US 11,261,239 | RSV F Protein Compositions and Method for Making Same In force · High confidence | GlaxoSmithKline Biologicals S.A. | In force | High confidence | ||
| Application 12/836,931 | RSV F Protein Compositions and Methods for Making Same Abandoned Abandoned Aug 30, 2017 | GlaxoSmithKline Biologicals S.A. | Abandoned | Abandoned Aug 30, 2017 | ||
| Application 18/323,166 | RSV F Protein Compositions and Methods for Making Same Abandoned Abandoned Jun 12, 2025 | GlaxoSmithKline Biologicals S.A. | Abandoned | Abandoned Jun 12, 2025 | ||
| Application 18/323,177 | RSV F Protein Compositions and Methods for Making Same Abandoned Abandoned Jul 25, 2025 | GlaxoSmithKline Biologicals S.A. | Abandoned | Abandoned Jul 25, 2025 | ||
| Application 18/323,185 | RSV F Protein Compositions and Methods for Making Same Abandoned Abandoned Aug 9, 2025 | GlaxoSmithKline Biologicals S.A. | Abandoned | Abandoned Aug 9, 2025 | ||
| Application 18/323,192 | RSV F Protein Compositions and Methods for Making Same Abandoned Abandoned Jun 5, 2025 | GlaxoSmithKline Biologicals S.A. | Abandoned | Abandoned Jun 5, 2025 | ||
| 2 more records in this group · Pro | ||||||
10 of 12 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 12.
5 of these are in force and held by GlaxoSmithKline Biologicals S.A..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.